Recalls / Active ingredient / Ropivacaine Hydrochloride
Ropivacaine Hydrochloride
1 FDA drug recall involving the active ingredient “Ropivacaine Hydrochloride” — 1 Class I.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-04-17 | Class I | Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceut | Amneal Pharmaceuticals, LLC |